A. Ben Saad (Monastir, Tunisia), C. Hernandez Carcereny (Barcelona, Spain), W. Labaki (Ann Arbor, United States of America), M. Emtner (Uppsala, Sweden)
Late Breaking Abstract - Qter® and Creatine improve functional performance in COPD patients on long-term oxygen therapy
F. de Blasio (Turin, Italy), B. Celli (Boston, United States of America), F. Polverino (Boston, United States of America), R. Pastorelli (Milan, Italy), M. Ferrario (Milan, Italy), E. Wouters (Maastricht, Netherlands), S. Marinari (Chieti, Italy), F. De Benedetto (Chieti, Italy)
|  |
Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)
L. Fabbri (Gothenburg, Sweden), K. Rabe (Kiel, Germany), F. Martinez (New York, United States of America), G. Ferguson (Farmington Hills, United States of America), C. Wang (Beijing, China), M. Ichinose (Sendai, Japan), E. Bourne (Durham, United States of America), S. Ballal (Morristown, United States of America), P. Darken (Morristown, United States of America), K. Deangelis (Durham, United States of America), M. Aurivillius (Mölndal, Sweden), P. Dorinsky (Durham, United States of America), C. Reisner (Morristown, United States of America)
|  |
Pre-discharge assessment and outcomes of patients commenced on short-term oxygen therapy
D. Mudawi (Middlesbrough, United Kingdom), G. Antunes (Middlesbrough, United Kingdom), N. Miller-Biot (Middlesbrough, United Kingdom)
| |
Advance Care Planning in Patients with Chronic Obstructive Pulmonary Disease assessed for Long Term Oxygen Therapy
F. Hildebrand (Melbourne, Australia), C. Kein (Melbourne, Australia), E. Denton (Melbourne, Australia), S. Khov (Melbourne, Australia), B. Miller (Melbourne, Australia)
| |
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
O. Titova (St-Petersburg, Russian Federation), N. Kuzubova (St-Petersburg, Russian Federation), D. Sklyarova (St-Petersburg, Russian Federation), V. Volchkov (St-Petersburg, Russian Federation)
| |
Oxygen alert cards versus Oxygen Alert Wrist Bands (OxyBand) in COPD
E. Rickards (liverpool, United Kingdom), D. Wat (liverpool, United Kingdom), A. Mcgonigle (liverpool, United Kingdom), D. Green (liverpool, United Kingdom), O. Hampson (liverpool, United Kingdom), P. Stockton (liverpool, United Kingdom), S. Sibley (liverpool, United Kingdom)
| |
Follow up after end of trial: Evaluation of usage of oxygen-enriched nasal high flow treatment in COPD with chronic hypoxemic respiratory failure
L. Storgaard (Aalborg, Denmark), U. Weinreich (Aalborg, Denmark)
| |
COPD Management needs Hospital and Community multi-disciplinary teams to work together to optimise patient care.
M. Apps (Billericay, United Kingdom), D. Mukherjee (Basildon, United Kingdom), S. Abbas (Basildon, United Kingdom), J. Minter (Billericay, United Kingdom), K. Sanger (Billericay, United Kingdom), J. Whitfield (Billericay, United Kingdom), S. Field (Billericay, United Kingdom), S. Pearce (Billericay, United Kingdom), P. Rosier (Billericay, United Kingdom), L. Ateli (Billericay, United Kingdom), H. Olympio-Anang (Billericay, United Kingdom), C. Goodrich (Billericay, United Kingdom), K. Keeling (Billericay, United Kingdom), H. Hill (Billericay, United Kingdom), D. Carter (Billericay, United Kingdom), T. Gisby (Billericay, United Kingdom), B. Hawkes (Billericay, United Kingdom), S. Webb (Billericay, United Kingdom), S. Barfield (Billericay, United Kingdom), C. Wigmore (Billericay, United Kingdom), J. Downham (Billericay, United Kingdom), M. Haigh (Billericay, United Kingdom), P. Bannister (Billericay, United Kingdom), I. Young (Billericay, United Kingdom), A. Kopacz (Billericay, United Kingdom), J. Peacock (BasildonBillericay, United Kingdom)
| |
Mortality causes in patients with advanced lung disease in long term oxygen therapy
V. Oliveira (Uberlândia, Brazil), T. Bastos (Uberlândia, Brazil), I. Taliberti (Uberlândia, Brazil), T. Rodrigues (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), L. Goulart Filho (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil), M. Damian (Uberlândia, Brazil), M. Gomes (Uberlândia, Brazil)
| |
Improvements in activation for self-management in patients with chronic airway disease via the COPDnet diagnostic trajectory in secondary care; a pilot study.
J. Antons (Nijmegen, Netherlands), N. Koolen (Nijmegen, Netherlands), H. Niet Van Der (Nijmegen, Netherlands), B. Robberts (Nijmegen, Netherlands), N. Plat (Nijmegen, Netherlands), B. Borst Van Den (Nijmegen, Netherlands), H. Helvoort Van (Nijmegen, Netherlands), J. Hees Van (Nijmegen, Netherlands), A. Hul Van ’T (Nijmegen, Netherlands)
| |
Effect of endoscopic lung volume reductions in patients with emphysema – a single center experience
F. Baty (St. Gallen, Switzerland), T. Schneider (St. Gallen, Switzerland), K. Kozu (St. Gallen, Switzerland), L. Kern (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
| |
Telehealth care vs. standard care in COPD – an international randomised controlled trial (interim analysis)
F. Rassouli (St. Gallen, Switzerland), F. Baty (St. Gallen, Switzerland), D. Stolz (Basel, Switzerland), M. Kohler (Zürich, Switzerland), R. Thurnheer (Münsterlingen, Switzerland), T. Brack (Glarus, Switzerland), C. Kähler (Wangen, Germany), M. Tamm (Basel, Switzerland), S. Widmer (St. Gallen, Switzerland), U. Tschirren (St. Gallen, Switzerland), M. Brutsche (St. Gallen, Switzerland)
| |
Effects of an early rehabilitation program in COPD exacerbation, after an hospital discharge, one-year follow-up
F. Gonçalves Dos Santos Carvalho (Barcelona, Spain), C. Martínez Rivera (Barcelona, Spain), M. Boldó (Barcelona, Spain), I. García Olivé (Barcelona, Spain), A. Marín Tapia (Barcelona, Spain), A. Muñoz Ferrer (Barcelona, Spain), Z. Stojanovic (Barcelona, Spain), A. Francoso Vicente (Barcelona, Spain), S. Baeza Mena (Barcelona, Spain), A. Moreno García (Barcelona, Spain), L. Mendiluce Ochandorena (Barcelona, Spain), M. Dura Mata (Barcelona, Spain), J. Ruiz Manzano (Barcelona, Spain)
| |
The cost-effectiveness of physical activity in the management of COPD patients in the UK
M. Ramos (Zaventem, Belgium), M. Lamotte (Zaventem, Belgium), L. Gerlier (Zaventem, Belgium), P. Svangren (Gothenburg, Sweden), A. Miquel Cases (Cambridge, United Kingdom), J. Haughney (Aberdeen, United Kingdom)
| |
A retrospective review of MDT mortality prediction for patients with COPD using The Gold Standard Framework.
N. Hussain (Preston, United Kingdom), A. Boardman (Preston, United Kingdom), P. Marsden (Preston, United Kingdom), S. Gudur (Preston, United Kingdom), Z. Walker Frost (Preston, United Kingdom)
| |
BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY.
J. Belda (Valencia, Spain), I. Arroyo-Fernandez (Xativa, Spain), R. Lera-Alvarez (Valencia, Spain), F. Tatay-Soler (Vinaroz, Spain)
| |
A simple multifunctional tool for integrated care of COPD
K. Roy (Watford, United Kingdom), A. Marau (London, United Kingdom), L. Gora (London, United Kingdom), J. Shrestha (London, United Kingdom), G. Esmond (London, United Kingdom)
| |
Evaluation of ‘care bundles’ as a means of improving hospital care for patients with acute COPD: a case-study approach
K. Morton (Bristol, United Kingdom), A. Shaw (Bristol, United Kingdom), J. Calvert (Bristol, United Kingdom), M. Chalder (Bristol, United Kingdom), E. Sanderson (Bristol, United Kingdom), P. Dixon (Bristol, United Kingdom), S. Macneill (Bristol, United Kingdom), W. Hollingworth (Bristol, United Kingdom), S. Jenkins (Bristol, United Kingdom), C. Metcalfe (Bristol, United Kingdom), A. King (Bristol, United Kingdom), S. Purdy (Bristol, United Kingdom)
| |
Innovating the treatment of COPD exacerbations: a phone tele-system to increase Action Plan adherence
R. Farias (Montreal, Canada), M. Sedeno (Montreal, Canada), P. Li (Montreal, Canada), A. Joubert (Montreal, Canada), I. Drouin (Montreal, Canada), R. Abimaroun (Montreal, Canada), I. Ouellet (Montreal, Canada), D. Beaucage (Montreal, Canada), M. Abou Rjeili (Montreal, Canada), M. Patel (Montreal, Canada), J. Bourbeau (Montreal, Canada)
| |